Literature DB >> 11311135

Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.

A Bröer1, B Friedrich, C A Wagner, S Fillon, V Ganapathy, F Lang, S Bröer.   

Abstract

Heterodimeric amino acid transporters are comprised of a type-II membrane protein named the heavy chain (4F2hc or rBAT) that may associate with a number of different polytopic membrane proteins, called light chains. It is thought that the heavy chain is mainly involved in the trafficking of the complex to the plasma membrane, whereas the transport process itself is catalysed by the light chain. The 4F2 heavy chain (4F2hc) associates with at least six different light chains to induce distinct amino acid-transport activites. To test if the light chains are specifically recognized and to identify domains involved in the recognition of light chains, C-terminally truncated mutants of 4F2hc were constructed and co-expressed with the light chains LAT1, LAT2 and y(+)LAT2. The truncated isoform T1, comprised of only 133 amino acids that form the cytosolic N-terminus and the transmembrane helix, displayed only a slight reduction in its ability to promote LAT1 expression at the membrane surface compared with the 529 amino acid wild-type 4F2hc protein. Co-expression of increasingly larger 4F2hc mutants caused a delayed translocation of LAT1. In contrast to the weak effects of 4F2hc truncations on LAT1 expression, surface expression of LAT2 and y(+)LAT2 was almost completely lost with all truncated heavy chains. Co-expression of LAT1 together with the other light chains did not result in displacement of LAT2 and y(+)LAT2. The results suggest that extracellular domains of the heavy chain are responsible mainly for recognition of light chains other than LAT1 and that the extracellular domain ensures proper translocation to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311135      PMCID: PMC1221788          DOI: 10.1042/bj3550725

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

Review 1.  New glycoprotein-associated amino acid transporters.

Authors:  F Verrey; D L Jack; I T Paulsen; M H Saier; R Pfeiffer
Journal:  J Membr Biol       Date:  1999-12-01       Impact factor: 1.843

Review 2.  Surface antigen CD98(4F2): not a single membrane protein, but a family of proteins with multiple functions.

Authors:  R Devés; C A Boyd
Journal:  J Membr Biol       Date:  2000-02-01       Impact factor: 1.843

3.  Post-transcriptional regulation of the transferrin receptor and 4F2 antigen heavy chain mRNA during growth activation of spleen cells.

Authors:  S Teixeira; L C Kühn
Journal:  Eur J Biochem       Date:  1991-12-18

4.  The heterodimeric amino acid transporter 4F2hc/LAT1 is associated in Xenopus oocytes with a non-selective cation channel that is regulated by the serine/threonine kinase sgk-1.

Authors:  C A Wagner; A Bröer; A Albers; N Gamper; F Lang; S Bröer
Journal:  J Physiol       Date:  2000-07-01       Impact factor: 5.182

5.  Cloning and expression of a b(0,+)-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT. A new candidate gene for cystinuria.

Authors:  D P Rajan; R Kekuda; W Huang; H Wang; L D Devoe; F H Leibach; P D Prasad; V Ganapathy
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

6.  The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine.

Authors:  A Bröer; C A Wagner; F Lang; S Bröer
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

7.  Enhanced graphic matrix analysis of nucleic acid and protein sequences.

Authors:  J V Maizel; R P Lenk
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Differential influence of the 4F2 heavy chain and the protein related to b(0,+) amino acid transport on substrate affinity of the heteromeric b(0,+) amino acid transporter.

Authors:  D P Rajan; W Huang; R Kekuda; R L George; J Wang; S J Conway; L D Devoe; F H Leibach; P D Prasad; V Ganapathy
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

9.  Cysteine residues in the C-terminus of the neutral- and basic-amino-acid transporter heavy-chain subunit contribute to functional properties of the system b(0,+)-type amino acid transporter.

Authors:  G J Peter; T B Panova; G R Christie; P M Taylor
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

Review 10.  The use of Xenopus laevis oocytes for the functional characterization of heterologously expressed membrane proteins.

Authors:  C A Wagner; B Friedrich; I Setiawan; F Lang; S Bröer
Journal:  Cell Physiol Biochem       Date:  2000
View more
  19 in total

1.  The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis.

Authors:  Nina Schroeder; Che-Sheng Chung; Chein-Hung Chen; Chung-Lin Liao; Wen Chang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

2.  Novel cystine ester mimics for the treatment of cystinuria-induced urolithiasis in a knockout mouse model.

Authors:  Amrik Sahota; Jaspreet S Parihar; Kathleen M Capaccione; Min Yang; Kelsey Noll; Derek Gordon; David Reimer; Ill Yang; Brian T Buckley; Marianne Polunas; Kenneth R Reuhl; Matthew R Lewis; Michael D Ward; David S Goldfarb; Jay A Tischfield
Journal:  Urology       Date:  2014-10-24       Impact factor: 2.649

Review 3.  Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98.

Authors:  Hang Thi Thu Nguyen; Didier Merlin
Journal:  Cell Mol Life Sci       Date:  2012-03-30       Impact factor: 9.261

4.  Heterodimeric amino acid transporter glycoprotein domains determining functional subunit association.

Authors:  Raffaella Franca; Emilija Veljkovic; Stefan Walter; Carsten A Wagner; François Verrey
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

5.  Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer's Disease.

Authors:  Yijun Pan; Kotaro Omori; Izna Ali; Masanori Tachikawa; Tetsuya Terasaki; Kim L R Brouwer; Joseph A Nicolazzo
Journal:  Mol Pharm       Date:  2018-08-22       Impact factor: 4.939

Review 6.  The role of CD98 in astrocytic neoplasms.

Authors:  Hiroshi Nawashiro; Naoki Otani; Nariyoshi Shinomiya; Shinji Fukui; Namiko Nomura; Akiko Yano; Katsuji Shima; Hirotaka Matsuo; Yoshikatsu Kanai
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

7.  In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved.

Authors:  Remigius Agu; Hoang Vu Dang; Mark Jorissen; Tom Willems; Sandy Vandoninck; Johan Van Lint; Jackie V Vandenheede; Renaat Kinget; Norbert Verbeke
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

8.  Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc.

Authors:  Albert Rosell; Marcel Meury; Elena Álvarez-Marimon; Meritxell Costa; Laura Pérez-Cano; Antonio Zorzano; Juan Fernández-Recio; Manuel Palacín; Dimitrios Fotiadis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

Review 9.  The ancillary proteins of HATs: SLC3 family of amino acid transporters.

Authors:  Manuel Palacín; Yoshikatsu Kanai
Journal:  Pflugers Arch       Date:  2003-05-06       Impact factor: 3.657

Review 10.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.